IP Case Law › Patents › Bigtec Private Limited v. Assistant Controller of Patents an…
Relevant Acts and provisions
Patents Act, 1970
Section 117ASection 2(1)(ja)Section 3(c)
Provisions considered: Sections 2(1)(ja) and 3(c) of the Patents Act, 1970, in an appeal under Section 117A.
Brief facts
Bigtec appealed against an order rejecting its patent application for nucleotide sequences, reaction mixture, method and kit used to detect a virus by means of a probe and two primer sequences. The Assistant Controller refused the claims for lack of inventive step, holding that designing further oligonucleotide sequences was routine, and separately excluded the primer sequences under Section 3(c) as a mere discovery of sequences occurring in nature.
Issues before the Court
- Did the Controller err in rejecting the claimed probe and primer sequences for lack of inventive step without discussing the appellant's evidence of unexpected amplification effects?
- Do synthesised primer sequences used with a labelled probe fall within the Section 3(c) exclusion for mere discovery of a substance occurring in nature?
Court's findings
The Court held that the impugned order was silent on the amplification evidence submitted by the appellant comparing its claimed sequences with the prior art, even though that evidence was noted earlier in the order, and that the bare conclusion that devising probes and primers was routine experimentation could not stand without engaging with this evidence.
On Section 3(c), the Court observed that the exclusion applies only to a mere discovery of something by its isolation from nature, and does not extend to synthesised sequences, particularly where a sequence is conjugated with synthesised fluorophore and quencher labels.
The Court held that the conclusion that the primer sequences were unpatentable merely because the sequence listing identified a natural species of origin was recorded without addressing the appellant's explanation that this reflected a software convention, and required fresh reasoning.
Decision
Impugned order set aside; the matter was remanded to a different officer for reconsideration within a fixed period, with no opinion expressed on the merits.
Key legal principle / ratio
An objection that devising nucleotide probes or primers is routine experimentation lacking inventive step under Section 2(1)(ja) must engage with evidence of unexpected effects placed on record; and the Section 3(c) exclusion for mere discovery of substances occurring in nature does not apply to synthesised sequences merely because a sequence listing identifies a natural species of origin.
Keywords
Biotechnology Inventive Step Patent Prosecution Prior Art Section 3(c)
Read the judgment
More Patents judgments
Array Biopharma Inc v. Deputy Controller of Patents and Designs
A combination of distinct and independent active drugs, each with its own chemical identity and mechanism, does not fall under the Section 3(d) bar for derivatives of known substances. Using phrases such as 'for simultaneous, sepa…
Inventive StepMethod of TreatmentPharmaceutical CombinationPrior ArtPatentsBayer Corporation v. Union of India & Ors.
A compulsory licence under Section 84 of the Patents Act, 1970 may be granted where the reasonable requirements of the public with respect to a patented invention have not been satisfied, the invention is not available at a reason…
Compulsory LicencePublic HealthReasonably Affordable PriceSection 84PatentsBishwanath Prasad Radhey Shyam v. Hindustan Metal Industries
An improvement on a device or process already known must involve more than a routine workshop improvement; it must independently satisfy the tests of novelty and inventive step by producing a new result, a new article, or a better…
Inventive StepNoveltyObviousnessPatent Revocation